Imbrium Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of V117957 in Overactive Bladder Syndrome (NCT06024642) | Imbrium Therapeutics | 2022-06-30 |
| Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome (NCT06285214) | Imbrium Therapeutics | 2022-05-26 |
| Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation (NCT04035200) | Imbrium Therapeutics | 2019-09-23 |
Track Imbrium Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.